Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Mol Med ; 20(5): 683-7, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17912461

RESUMO

Plasminogen activator inhibitor-1 (PAI-1) is the major specific inhibitor of tissue-type plasminogen activator (tPA) which mediates fibrin clot lysis through activation of plasminogen. Wild-type-PAI-1 (wPAI-1) is rapidly converted to the latent form (half-life of approximately 2 h) and loses its ability to inhibit tPA. We developed a very long half-life PAI-1 (VLHL PAI-1), a recombinant protein with a half-life >700 h compared with wPAI-1. In this study, VLHL PAI-1 was assessed for its ability to inhibit clot lysis in vitro. Clot formation was initiated in normal plasma supplemented with tPA by the addition of either tissue factor or human recombinant FVIIa. Clot lysis time, monitored turbidimetrically in a microtiter plate reader, was determined at various concentrations of wPAI-1 and VLHL PAI-1. Both wPAI-1 and VLHL PAI-1 caused a significant increase in clot lysis time, although the latter was somewhat less effective at lower concentrations. The VLHL PAI-1, but not wPAI-1, maintained its anti-fibrinolytic activity after preincubation overnight at 37 degrees. These studies demonstrate that VLHL PAI-1 is an effective inhibitor of fibrin clot degradation. Due to the high stability of VLHL PAI-1 compared with wPAI-1, this novel inhibitor of tPA-mediated fibrinolysis may have therapeutic applications for treating surgical and trauma patients when used directly or in conjunction with the procoagulant recombinant FVIIa.


Assuntos
Coagulação Sanguínea/efeitos dos fármacos , Fibrina/metabolismo , Fibrinólise/efeitos dos fármacos , Inibidor 1 de Ativador de Plasminogênio/farmacologia , Proteínas Recombinantes/farmacologia , Ativador de Plasminogênio Tecidual/farmacologia , Eletroforese em Gel de Poliacrilamida , Meia-Vida , Humanos , Inibidor 1 de Ativador de Plasminogênio/isolamento & purificação , Espectrofotometria , Termodinâmica
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa